Acutus Medical to Announce Third Quarter 2021 Financial Results
Acutus Medical (AFIB) is set to announce its third-quarter 2021 financial results on November 11, 2021. The company will host a conference call at 1:30 PM PT / 4:30 PM ET, where it will discuss financial outcomes and recent developments. Interested investors can join by dialing specific numbers or through the investor relations website. Acutus specializes in arrhythmia management, providing innovative electrophysiology products aimed at improving diagnosis and treatment efficiency.
- Upcoming release of Q3 2021 financial results on November 11, 2021.
- Conference call for investors to discuss financial results and highlights.
- None.
CARLSBAD, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today it will release its financial results for the third quarter of 2021 on Thursday, November 11, 2021. In conjunction with the release, Acutus will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.
Interested parties may access the live call via telephone by dialing (833) 570-1131 for domestic callers or (914) 987-7078 for international callers, using conference ID: 7373938. The live webinar of the call may be accessed by visiting the Events section of the Acutus investor relations website at ir.acutusmedical.com. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on the company’s website following the earnings call.
About Acutus Medical
Acutus is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. Acutus is committed to advancing the field of electrophysiology with a unique array of products and technologies which will enable more physicians to treat more patients more efficiently and effectively. Through internal product development, acquisitions and global partnerships, Acutus has established a global sales presence delivering a broad portfolio of highly differentiated electrophysiology products that provide its customers with a complete solution for catheter-based treatment of cardiac arrhythmias. Founded in 2011, Acutus is based in Carlsbad, California.
Investor Contact:
Caroline Corner
Westwicke ICR
D: 415-202-5678
caroline.corner@westwicke.com
Holly Windler
M: 619-929-1275
media@acutusmedical.com
FAQ
When will Acutus Medical release its Q3 2021 financial results?
What time is the Acutus Medical conference call on November 11, 2021?
How can I access the Acutus Medical Q3 results call?
What is Acutus Medical's focus in the healthcare industry?
